Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 2/14/20 → 2/28/23 |
Funding
- Janssen Research and Development LLC: $51,621.00
A Phase 3b, Randomized, Double-blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Re-induction Therapy With Ustekinumab in Patients with Moderately to Severely Active Crohn's Disease
- Flomenhoft, Deborah (PI)
- Leyson, Christina (Former CoI)
- Stuffelbeam, Amy (Former CoI)